Abstract:Introduction: A major requirement in bone tissue engineering is the persistent and robust promotion of osteogenesis, which requires sustained stimulation with osteoinductive factors, such as bone morphogenetic protein-2 (BMP-2). However, the direct application of these factors remains challenging due to their short half-life and rapid systemic clearance. Given the well demonstrated benefits of recombinant adeno-associated viral (rAAV) vector, including long-term gene transfer efficiency and relative safety, rAAV-based therapies have been developed in both basic and translational research. However, traditional ex vivo gene transduction process is time consuming and requires multiple steps of cell culture. In addition, rAAV shows inconsistent transfection efficacy in primary cells. In this study, we co-packed rAAV-BMP-2 and human bone marrow stem cells (hBMSCs) into a gelatin scaffolds through one-step visible light-based phtocorsslinking (PXL), and tested their application for bone regenerationi. We hypothesize that the concentrated and localized release of rAAV-BMP-2 from the scaffold matrix results in higher transfection efficacy and BMP-2 expression in hBMSCs seeded within the scaffolds, thus enhancing their osteogenic differentiation and bone formation upon implantation in bone defect. Methods: hBMSCs were obtained with IRB approval from total joint arthroplasty patient. The rAAV6-BMP-2 and rAAV6-GFP reporter (as control) vectors were designed and prepared using an established protocol in our laboratory. PXL was performed using 10% gelatin and 10×106 hBMSCs/ml with different amount of rAAV6-GFP. Transfection efficiency was determined by counting GFP-positive cells ratio as well as assessing cell viability. At an optimal ratio, rAAV-BMP-2 and hBMSCs were included into gelatin through PXL. At different time point, BMP-2 production and rAAV6 release kinetics were analyzed. The osteogenesis of hBMSCs was assessed at day 28 by real time PCR and histological staining. In animal study, a 0.5 cm diameter critical size of cranial bone defect model was generated in SCID mice and then the constructs described above were transplanted. Micro-CT imaging and histological staining were used to evaluate the skull bone healing process up to 6 weeks. Results: Both rAAV and hBMSCs survived during the scaffold fabrication process. 10×104 rAAV/hBMSCs was shown to be the optimal ratio in maintaining cell viability and achieving transduction efficiency. After in situ transfection within scaffolds, hBMSCs produced higher BMP-2 amount than those subjected to traditional ex vivo transduction process, and underwent robust osteogenesis as well. In animal study, micro-CT imaging results indicated that rAAV BMP-2 & hBMSCs-activated gelatin scaffolds effectively promoted bone regeneration in mice cranial bone defect, in a manner significantly superior to that of scaffolds loaded with hBMSCs/BMP-2 protein, and was remarkably compatible to scaffolds loaded with hBMSCs previously ex vivo transduced by rAAV-BMP-2. The histological staining further confirmed the efficacious bone formation from rAAV BMP-2 & hBMSCs loaded scaffold. The results shown here thus demonstrate the feasibility of combining gene and cell therapy with biomaterial engineering via a single-step fabrication and its application for the repair of bone defect.

Synthesis of a novel targeted-nonviral vector K16GRGDSPC oligopeptide and gene delivery to bone marrow stromal cells mediated by the peptide

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.

Novel Synthesized Nanofibrous Scaffold Efficiently Delivered hBMP-2 Encoded in Adenoviral Vector to Promote Bone Regeneration

Effects on Proliferation and Osteoblastic Phenotype of Rabbit Bone Marrow Stromal Cells Transfected with Transforming Growth Factor-beta 1 Gene Mediated with RGD-containing Peptide Gene Delivery System in Vitro

TARGETED GENE DELIVERY TO MESENCHYMAL STEM CELLS USING NANOPARTICLES

Manipulation of Transgene Expression in Fibroblast Cells by a Multifunctional Linear-Branched Hybrid Poly(β-Amino Ester) Synthesized Through an Oligomer Combination Approach.

Construction Of A Tumor Cell-Targeting Non-Viral Gene Delivery Vector With Polyethylenimine Modified With Rgd Sequence-Containing Peptide

Effective Gene Delivery to Mesenchymal Stem Cells Using A Synthesized Vector, Chitosan-Linked-Polyethylenimine

Efficient Gene Transfer to Rat Fetal Osteoblastic Cells by Synthetic Peptide Vector System

Biodegradable Antibacterial Branched Glycerol-Polypeptide With Efficient In Vitro/In Vitro Mirna-29b Delivery For Promoting Osteogenic Differentiation Of Stem Cells And Bone Regeneration

524. Injectable BMP-2 Gene-Activated Scaffold for the Repair of Mouse Cranial Bone Defect

High Efficiency Intracellular Transport of Cationic Peptide Stearate for Gene Delivery in Tumor Cells and Multipotent Stem Cells

Bone Formation Promoted by Bone Morphogenetic Protein-2 Plasmid-Loaded Porous Silica Nanoparticles with the Involvement of Autophagy

Spatiotemporal Delivery of pBMP2 and pVEGF by a Core‐Sheath Structured Fiber‐Hydrogel Gene‐Activated Matrix Loaded with Peptide‐Modified Nanoparticles for Critical‐sized Bone Defect Repair

TPGS-b-PBAE Copolymer-Based Polyplex Nanoparticles for Gene Delivery and Transfection In Vivo and In Vitro

A Novel Gene Delivery System Targeting Cells Expressing VEGF Receptors

Oligohistidine and targeting peptide functionalized TAT-NLS for enhancing cellular uptake and promoting angiogenesis in vivo

Conjugation of membrane-destabilizing peptide onto gelatin–siloxane nanoparticles for efficient gene expression

[Study on Biological Activity of Recombinant Adeno-Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor 165 and Human Bone Morphogenetic Protein 7 Genes in Vitro].

Cationic RGD peptidomimetic nanoconjugates as effective tumor targeting gene delivery vectors with antimicrobial potential